IFP Advisors’s Kite Pharma, Inc. KITE Stock Holding History

IFP Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3	Closed	-$1K	–	4365
2017 Q3	$1K	Buy	+3	New	+$418	﹤0.01%	4033
2017 Q2	–	Sell	-175	Closed	-$14K	–	4350
2017 Q1	$14K	Sell	175 -1,525	-90%	-$94.3K	﹤0.01%	2747
2016 Q4	$76K	Buy	1,700 +950	+127%	+$46.6K	﹤0.01%	1626
2016 Q3	$42K	Buy	750 +70	+10%	+$3.9K	﹤0.01%	1932
2016 Q2	$34K	Buy	+680	New	+$33.4K	﹤0.01%	2001
2016 Q1	–	Sell	-150	Closed	-$9K	–	4027
2015 Q4	$9K	Buy	+150	New	+$10.6K	﹤0.01%	2663

IFP Advisors's KITE Position: Q4 2017 in Review

IFP Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 3 shares — an estimated $1K sold.

IFP Advisors first reported a position in KITE in Q4 2015 and held it in 6 quarters. The position peaked at $76K in Q4 2016. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

IFP Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
IFP Advisors sold 3 Kite Pharma, Inc. shares in Q4 2017, an estimated $1K.
IFP Advisors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 6 quarters.
IFP Advisors's Kite Pharma, Inc. position peaked at $76K in Q4 2016.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.